Adar Poonawalla ‘hopes to launch COVOVAX by June 2021’

Adar Poonawalla hopes to launch COVOVAX by June 2021

Serum Institute India chief Adar Poonawalla has announced that the company may launch a second coronavirus vaccine in June this year. If approved, it could be India’s third coronavirus vaccine. Poonawalla said that SII’s partnership with Novavax, a vaccine undergoing trials for effectiveness against the novel coronavirus, has published ‘excellent efficacy results’.

Poonawalla took to Twitter saying, “Our partnership for a COVID-19 vaccine with @Novavax has also published excellent efficacy results. We have also applied to start trials in India. Hope to launch #COVOVAX by June 2021!” On January 16, India began a nation-wide inoculation drive after the drug regulator DCGI approved two vaccines – the SII’s Covishield and Bharat Biotech’s Covaxin for emergency use. Covishield has been developed in partnership with the Oxford University and British-Swedish firm AstraZeneca.